a monoclonal antibody linked to a toxic substance. it is being studied in the treatment of some types of b-cell cancer. cat-8015 is made in the laboratory. it binds to cd22, a protein on the surface of normal b cells and b-cell tumors, and kills the cells. also called anti-cd22 immunotoxin cat-8015.